Lauren Santye, Assistant Editor

Response times found to be 10% slower in people with Crohn’s disease than those without the disease.

New research compares cardiovascular issues among patients with type 2 diabetes and psoriasis.

Novel drug is a bispecific T cell engager (BiTE) that targets the B-cell maturation antigen in multiple myeloma.

Top news of the day from across the health care landscape.

Underlying mechanisms of skin cancer reveal potential avenue to cure melanoma.

Expanded use of bundled payments in cancer for services such as mammography.

National Institutes of Health awards $9.4 million to improve HIV health care.

Daniel P. Kus, BS Pharm, RPh, vice president of Pharmacy Advantage, discusses how specialty pharmacies can optimize the prior authorization process.

PCSK9 inhibitor alirocumab (Praluent) achieves positive results lowering LDL cholesterol in patients with heterozygous familial hypercholesterolemia.

Researchers reveal how anti-HIV inhibitors bind to the wrong target.

Praluent lowers LDL cholesterol in patients with heterozygous familial hypercholesterolemia (HeFH).

CRISPR-Cas9 stabilizes the guide RNA in live cells.

Combinations with hypoxia-activated prodrugs may eliminate non-small cell lung cancer tumors.

Top news of the day from across the healthcare landscape.

Omega-3 fatty acid supplements may help address the growing prevalence of type 2 diabetes mellitus and diabetic retinopathy.

Paul LeVine, vice president of Analytic Services at TrialCard, discusses how specialty pharmacies can best utilize data to improve patient outcomes.

The toxicity of cancer drugs increasingly causing cardiovascular complications in patients.

Top news of the day from across the health care landscape.

Researchers seek to reduce the significant HIV risk among homeless people.

Research advances work towards targeted therapies for type 2 diabetes.

FDA advises nucleic acid tests to screen for hepatitis B virus.

Self-reported psychological well-being superior in patients with leukemia after a bone marrow transplant compared with peripheral blood transplants.

Some breast cancer tumors are not sensitive to Herceptin.

Researchers examine whether cognitive impairment caused by chemotherapy drugs in breast cancer patients is a long-term issue.

Top news of the day from across the healthcare landscape.

Cancer genomics reveal genetic mutations that aid tumor growth in prostate cancer.

Treating cellular survival mechanism may prove to be a promising treatment approach for cancer.

Prescribed diabetes therapies may be leading to reduced kidney function.

New method able to reduce toxic side effects by avoiding use of chemotherapy.

Test can identify multiple sclerosis from other neurological conditions.